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Background: Infants and children who undergo surgical repair of complex congeni-
tal heart diseases are prone to developing renal dysfunction. The purpose of this 
study was to investigate the risk factors associated with prolonged peritoneal dial-
ysis (PD) and the mortality of pediatric patients with acute renal failure (ARF) after 
open heart surgery.
Methods: From June 1999 to May 2007, a total of 542 children underwent open 
heart surgery for congenital heart disease. Fifteen (2.8%) experienced ARF and 
seven (1.3%) required PD. The clinical and laboratory variables were compared 
between the survivor and non-survivor groups of ARF patients that needed PD.
Results: The non-survivors (n = 3, 43%) had a longer cardiopulmonary bypass time 
(154 ± 21 vs. 111 ± 8 minutes, p = 0.012) and longer aorta clamping time (92 ± 40 vs. 
66 ± 15 minutes, p = 0.010) than the survivors (n = 4, 57%). Before the PD, the pH and 
base excess of the arterial blood gas analysis in the survivors was much higher than 
that non-survivors (7.30 ± 0.04 vs. 7.16 ± 0.10, p = 0.039; −5.15 ± 3.13 vs. −12.07 ± 
2.9 mmol/L, p = 0.031). Furthermore, the survivors had a shorter interval between 
the onset of ARF and the day the PD was begun (1.2 ± 0.4 vs. 4.3 ± 1.2 days, p = 0.001), 
and shorter duration of PD (6.6 ± 2.7 vs. 13.0 ± 3.5 days, p = 0.036) than non-survivors.
Conclusion: Early intervention with PD is a safe and effective method for managing 
patients with ARF after open heart surgery. The cardiopulmonary bypass and aortic 
clamping duration, time of initiating PD, duration of the PD, sepsis, and relative 
complications may predict the prognosis of these patients.
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1. Introduction
The development of acute renal failure (ARF) is a 
frequently reported complication after cardiopul-
monary bypass surgery in infants and children. 
Studies have reported a high mortality rate—ranging 
from 30−79%.1−3 Fluid restrictions, diuretics, and 
inotropic agents have been the initial therapeutic 
strategies for mild renal dysfunction and low cardiac 
output syndrome. The more severe cases require a 
slow and continuous removal of the fluid by hemo-
filtration or peritoneal dialysis (PD). Compared with 
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hemofiltration, PD in pediatric patients is associated 
with advantages in the establishment of vascular 
access, avoidance of systemic anticoagulation, and 
decreased associated risks of ischemic and embolic 
complications.4,5
The feasibility and efficacy of PD, optimal timing 
of application, complications, prognosis, and pre-
dictive risk factors of the mortality in children un-
dergoing PD after open heart surgery are currently 
under discussion.1,2,6−9 We reviewed our experience 
with PD in treating children with ARF after surgical 
repair of congenital heart disease. The aims of this 
study were: (1) to determine the differences in 
clinical and laboratory variables between survivors 
and non-survivors receiving PD; (2) to identify 
risk factors predisposing to a prolonged PD and 
mortality; (3) to improve the future application 
and success of PD in pediatric patients with renal 
dysfunction after open heart surgery.
2. Materials and Methods
2.1. Study population
From June 1999 to May 2007, the medical records 
of 542 children that underwent open heart surgery 
at Taipei Veterans General Hospital were reviewed 
retrospectively. Among them, 15 (2.7%) experi-
enced ARF after open heart surgery; six received 
conservative medical treatment only, two received 
continuous veno-venous hemofiltration, and seven 
received PD. We divided the seven patients who 
underwent PD into two groups depending on the 
outcome: group I, three children (42%) died after 
PD; group II, four children (58%) survived after PD.
2.2.  Acute renal failure (ARF) and 
peritoneal dialysis (PD)
ARF was defined as a creatinine level of more than 
1.2 mg/dL or oliguria (< 0.5 mL/kg/hour) for more 
than 4 hours despite aggressive di uretic therapy 
and optimization of the inotropic support, or a 
combination of both.6 The indications for PD in-
cluded: (1) hypervolemia with severe edema; (2) 
anuria or oliguria for more than 4 hours despite ag-
gressive diuretic and inotropic support; (3) hyper-
kalemia (> 5.5 mmol/L); (4) metabolic acidosis 
(serum pH < 7.3, HCO3 < 18 mmol/L)—persistent after 
failing to be corrected by at least two boluses of an 
intravenous sodium bicarbonate infusion and ad-
justment of the fluid status with an inotropic support; 
(5) low cardiac output with renal insufficiency.
The PD catheter was connected to a closed sys-
tem for peritoneal drainage. The dialysate solutions 
used were standard commercial preparations (Dianel 
PD-2; Baxter International Inc., Deerfield, IL, USA); 
heparin (500 U/L of dialysate) and potassium chloride 
were added. The dextrose concentration varied from 
1.5−4.5%, and the choice of dextrose concentration 
depended on the presence of serum hyperglycemia. 
PD was started with a dwell volume from 10 mL to 
20 mL/kg with a dwell time of 1−2 hours. The recov-
ery of the urine output was defined as a urine out-
put > 1 mL/kg/hour, and the recovery of serum 
creatinine was defined as a decline in serum creati-
nine to preoperative levels. Indications for stopping 
PD included a return to a sufficient urine output, 
maintaining a negative fluid balance, and normaliza-
tion of the serum electrolytes and acid-base status.
2.3. Data collection and analysis
The age and body weight, diagnosis of the congenital 
heart disease, surgical procedure performed, cardio-
pulmonary bypass time, and aorta clamping duration 
were recorded. For the patients who experienced 
acute renal failure, the following data were collected 
before PD: pH, bicarbonate levels, base excess lev-
els, serum potassium levels, serum blood urea nitro-
gen levels, serum creatinine levels, and daily urinary 
output. The fluid balance and fluid supply per kilo-
gram of bodyweight during the 4 hours before the 
initiation of the PD were calculated. For patients 
requiring PD, we recorded the following: time to 
onset of acute renal failure, indication for PD, dura-
tion of PD, time interval between PD and peak cre-
atinine level, time interval between PD and urine 
output recovery, and time interval between PD and 
creatinine recovery. Additionally, the total dura-
tion of the mechanical ventilation, inotropic agent 
therapy, and PD complication were recorded. The 
prognosis and cause of death were noted.
Data are expressed as the mean ± standard devi-
ation or median (range) as appropriate. Univariate 
analysis was performed to compare the demo-
graphic data. The Mann-Whitney U test was used to 
compare preoperative, intraoperative, and postop-
erative variables between the survivors and non-
survivors of PD. A p value of < 0.05 was considered 
statistically significant. All statistical analyses were 
performed using SigmaStat® 3.1 (Jandel Scientific, 
San Rafael, CA, USA).
3. Results
Seven (47%) children were managed with PD for ARF; 
the patients’ age, type of congenital heart defect, 
and operation are shown in Table 1. The cause of 
death in non-survivors included infection (sepsis, 
infective endocarditis, and disseminated intravas-
cular coagulopathy) in two patients, and pump failure 
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(congestive heart failure, extensive myocardial in-
jury, and cardiogenic shock) in one patient. However, 
there were no deaths directly attributable to the 
PD complication. The four survivors experienced a 
period of a low cardiac output and systemic hypo-
tension, which was suspected to be the cause of 
the ARF in the postoperative period.
The indications and complications of PD are shown 
in Table 2. The clinical and laboratory comparisons 
between the two groups are shown in Table 3. The 
non-survivors had a longer cardiopulmonary bypass 
time (154 ± 21 vs. 111 ± 8 minutes, p = 0.012) and 
longer aorta clamping time (92 ± 40 vs. 66 ± 15 min-
utes, p = 0.010) than survivors (n = 4, 57%). Before PD, 
the pH and base excess of arterial blood gas in the 
survivors was much higher than in non-survivors 
(7.30 ± 0.04 vs. 7.16 ± 0.10, p = 0.039; −5.15 ± 3.13 
vs. −12.07 ± 2.9 mmol/L, p = 0.031). Furthermore, 
the survivors had a shorter interval between the 
onset of the ARF and PD (1.2 ± 0.4 vs. 4.3 ± 1.2 days, 
p = 0.001), a shorter duration of PD (6.6 ± 2.7 vs. 13.0 ± 
3.5 days, p = 0.036), less inotropic agent therapy 
(10.0 ± 4.2 vs. 24.3 ± 5.5 days, p = 0.011), less mecha-
nical ventilation therapy (7.4 ± 2.2 vs. 26.3 ± 6.4 days, 
p = 0.002), and lower incidence of hyperglycemia 
(2.8 ± 2.2 vs. 7.7 ± 1.5 days, p = 0.022).
4. Discussion
Early intervention with PD is a safe and effective 
method for managing patients with ARF after open 
heart surgery. The risk factors for a prolonged PD and 
mortality include: (1) prolonged cardiopulmonary 
bypass time; (2) prolonged aortic clamping time; (3) 
significant metabolic acidosis before PD; (4) delayed 
timing in beginning PD; (5) associated infections.
Table 1 Demographic data of seven patients who underwent peritoneal dialysis after open heart surgery
No. Age Diagnosis Open heart surgery Mortality
1  4 yr DORV, remove type VSD,  Total correction Yes
   pulmonary stenosis
2 10 d Congenital mitral stenosis, Mitral valve commissurotomy Yes
   hypoplastic left heart, CoA,   & ASD repair
   PDA, pulmonary hypertension
3  4 yr TOF, MAPCAs Total correction, surgical  Yes
    ligation of an MAPCA
4  9 d CoA, VSD, PDA Two stages: (1) correction of a CoA,  No
    ligation of a PDA; (2) VSD repair
5  5 mo TOF Total correction No
6 15 d TOF, PA, MAPCAs RVOT reconstruction  No
7 14 mo TOF Total correction No
ASD = atrial septal defect; CoA = coarctation of the aorta; DORV = double outlet of the right ventricle; MAPCAs = major aortopul-
monary collateral arteries; PA = pulmonary atresia; PDA = patent ductus arteriosus; RVOT = right ventricle outflow tract; 
TOF = tetralogy of Fallot; VSD = ventricular septal defect.
Table 2  Indications and complications for peritoneal 
dialysis
 Non-survivors   Survivors
 group I (n = 3) group II (n = 4)
Hypervolemia 3 4
Oliguria 0 3
Anuria 3 1
Hyperkalemia 2 1
Metabolic acidosis 3 2
Complications  
Hyperglycemia 2 2
Electrolyte  3 1
 imbalance
The incidence of ARF after cardiopulmonary by-
pass surgery in our infants and children was 2.7%, 
which was relatively low in comparison to previous 
published reports (1.6−17%).8,10,11 ARF is often re-
lated to underlying defects in the patients and the 
complexity of the operation. The more complicated 
the cardiac lesions and cyanotic heart disease is, 
the longer the cardiopulmonary bypass time that is 
required and the higher the incidence of postop-
erative ARF.12
PD is currently chosen as the primary renal re-
placement therapy because it is relatively easy to 
employ, is efficacious, and has a low complication 
rate.4,5,10,11,13,14 This is contrary to continuous veno-
venous and arterio-venous hemofiltration, which 
requires anticoagulation and vascular access, and 
may lead to complication, especially in neonates 
and young infants.4,6,7 The mortality rate in our pa-
tients after PD was 42%, a finding comparable with 
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other reports (24−79%).6,8,11,13,14 However, the vari-
ation in patient demographics, operational complex-
ity, dialysis modality, and indication for initiation 
of renal support makes the comparison of the out-
come difficult.
In the present study, we found that the cardio-
pulmonary bypass time, aorta clamp time, acidosis 
before PD, and the timing of the initiation of 
PD affected the prognosis in ARF patients. A pro-
longed cardiopulmonary bypass triggers important 
inflammatory reactions, including the release of 
kinin, coagulation factor XII, complement factors 
by endothelial cells, and leucocytes—the reactions 
are associated with capillary leak syndrome, re-
sulting in hypovolemia and renal hypoperfusion.10,15 
Furthermore, a prolonged aorta clamp time may 
decrease tissue perfusion, possibly causing ischemic 
injury. Acidosis, including the lowering of pH, HCO3 
and base excess, has been used as an indicator of 
the severity of the shock, to discriminate survivors 
from non-survivors, and has been strongly correlated 
with lactate, another serious indicator of potential 
mortality.16,17
The optimal timing for intervention with PD is 
still controversial.1,2,6 Many authors have suggested 
that early intervention with PD is needed—as soon 
as ARF occurs. Dittrich et al used a prophylactic 
and early start of PD when the risk factors for ARF 
were present; they reported a better control of 
fluid balance and a more favorable patient out-
come, with a mortality rate of 27%.6 In the present 
study, the time of the application of the PD in the 
survivors was significantly earlier than non-survivors. 
This change in treatment time was caused by a 
change in hospital policy for treating ARF patients 
after open heart surgery—for the last 3 years, renal 
replacement therapy has been a requirement. We 
do not wait to start PD until a low cardiac output, 
hypervolemia, edema, anuria, progressive renal func-
tion impairment or severe acidosis occur; instead, 
we introduce PD if the patient has risk factors for 
ARF and when a low cardiac output, oliguria, and 
hypervolemia are present. In our limited experi-
ence, the fluid balance status improves remark-
ably after initiation of PD. No major complications 
related to the PD were noted—including catheter 
Table 3 Comparison of clinical and laboratory variables between the two groups of patients with acute renal failure 
requiring penitoneal dialysis
Variables Non-survivors group I (n = 3) Survivors group II (n = 4) p
Age (mo) 32.4 ± 27.5 4.9 ± 6.4 0.090
Sex (male:female) 1:2 3:1
Body weight at surgery (kg) 13.3 ± 9.9 5.1 ± 3.2 0.172
CPB time (min) 154.0 ± 21.1 111.3 ± 7.5 0.012*
Cross-clamp time (min) 92.0 ± 40.1 65.5 ± 14.8 0.010*
Onset of ARF after surgery (d) 3.7 ± 2.9 5.2 ± 3.2 0.552
Beginning of PD (d) 7.6 ± 5.0 6.4 ± 3.6 0.688
Before PD
 pH 7.16 ± 0.10 7.30 ± 0.04 0.039*
 Bicarbonate (mmol/L) 13.2 ± 1.06 19.5 ± 3.4 0.029*
 Base excess (mmol/L) −12.07 ± 2.9 −5.15 ± 3.13 0.031*
 Potassium (mmol/L) 4.4 ± 1.2 5.6 ± 1.5 0.229
 BUN (mg/dL) 47.7 ± 19.3 35.0 ± 36.5 0.250
 Creatinine (mg/dL) 2.7 ± 2.8 1.5 ± 1.1 0.397
Interval between ARF & the  4.3 ± 1.2 1.2 ± 0.4 0.001*
 beginning of PD (d)
Duration of PD (d) 13 ± 3.5 6.6 ± 2.7 0.036*
Interval between PD & peak Cr (d) 6.3 ± 0.6 2.5 ± 1.3 0.005*
Interval between PD & UO recovery (d)  − 4.8 ± 2.7 −
Interval between PD & Cr recovery (d) − 9.8 ± 5.9 −
Duration of inotropic agents (d) 24.3 ± 5.5 10 ± 4.2 0.011*
Time of mechanical ventilation (d) 26.3 ± 6.4 7.4 ± 2.2 0.002*
Duration of hyperglycemia (d) 7.7 ± 1.5 2.8 ± 2.2 0.022*
*p < 0.05. ARF = acute renal failure; CPB = cardiopulmonary bypass; BUN = blood urea nitrogen; Cr = creatinine; PD = peritoneal 
dialysis; UO = urine output.
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leak, peritonitis, bowel perforation, or hemorrhage. 
However, hyperglycemia was found in two survivors 
and two non-survivors, and an electrolyte imbalance 
was found in one survivor and three non-survivors. 
The complication rate in the present study was quite 
low, and the safety was comparable with other se-
ries (20−75%).1,18 The renal function normalized in 
all four surviving children, and this rate was in 
agreement with the other studies.10,19
We further determined other risk factors asso-
ciated with a longer duration of PD. The risk factors 
included the postoperative occurrence of low cardiac 
output syndrome, prolonged inotropic agent ther-
apy and postoperative ventilator settings, associated 
sepsis, bacteremia, infective endocarditis, dissemi-
nated intravascular coagulopathy, and multiple organ 
failure. All of these conditions affect the duration 
of hospitalization, and the survival rate of children 
requiring PD. By comparing the differences in vari-
ables between survivors and non-survivors, we can 
predict the prognosis of patients receiving PD after 
cardiac surgery.
Because only small patient numbers were en-
rolled in both groups, grouping for statistical anal-
ysis was not satisfactory, and the study had a low 
statistical power. More studies are needed to in-
vestigate the risk factors of prolonged PD and mor-
tality in pediatric patients with ARF.
In conclusion, PD is effective in achieving a neg-
ative fluid balance and producing fewer hemody-
namic changes in infants and young children with 
acute renal failure after open heart surgery. For 
such high-risk infants or children with ARF, we sug-
gest prophylactic or early intra-operative placement 
of PD catheters. Early intervention with PD for a 
more rapid institution of renal replacement ther-
apy can effectively avoid the need for severe fluid 
restrictions and the potential of a progressive car-
diorespiratory compromise. The cardiopulmonary 
bypass duration, low cardiac output syndrome, time 
of PD initiation, duration of PD, sepsis, and relative 
complications could help to predict the prognosis 
of PD in patients with ARF after open heart surgery.
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